Monogram Orthopaedics Inc. Common Stock (MGRM) Stock Forecast
Alert
Its only available to paid users.
USD 4.00
(+55.04%)
Based on the Monogram Orthopaedics Inc. Common Stock stock forecast from 1 analysts, the average analyst target price for Monogram Orthopaedics Inc. Common Stock is USD 4.00 over the next 12 months. Monogram Orthopaedics Inc. Common Stock’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Monogram Orthopaedics Inc. Common Stock is Bearish, which is based on 1 positive signals and 7 negative signals. At the last closing, Monogram Orthopaedics Inc. Common Stock’s stock price was USD 2.58. Monogram Orthopaedics Inc. Common Stock’s stock price has changed by -3.01% over the past week, +30.30% over the past month and -18.10% over the last year.
No recent analyst target price found for Monogram Orthopaedics Inc. Common Stock
No recent average analyst rating found for Monogram Orthopaedics Inc. Common Stock
Company Overview Monogram Orthopaedics Inc. Common Stock
Monogram Technologies Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Orthopaedics, Inc. and changed its name to Monogram Technologies Inc. in May 2024. Monogram Technologies Inc. was founded in 2015 and is headquartered in Austin, Texas. Read Less
Monogram Technologies Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation con...Read More
Frequently Asked Questions About Monogram Orthopaedics Inc. Common Stock (MGRM) Stock
Based on ratings from 1 analysts Monogram Orthopaedics Inc. Common Stock's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on MGRM's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for MGRM is USD 4.00 over the next 12 months. The maximum analyst target price is USD 4 while the minimum anlayst target price is USD 4.
Unfortunately we do not have enough data on MGRM's stock to indicate if its overvalued.
The last closing price of MGRM's stock was USD 2.58.
The most recent market capitalization for MGRM is USD 0.09B.
Based on targets from 1 analysts, the average taret price for MGRM is projected at USD 4.00 over the next 12 months.
This means that MGRM's stock price may go up by +55.04% over the next 12 months.
We can't find any ETFs which contains Monogram Orthopaedics Inc. Common Stock's stock.
As per our most recent records Monogram Orthopaedics Inc. Common Stock has 28 Employees.
Monogram Orthopaedics Inc. Common Stock's registered address is 3913 Todd Lane, Austin, TX, United States, 78744.
You can get more information about it from Monogram Orthopaedics Inc. Common Stock's website at https://www.monogramorthopedics.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Monogram Orthopaedics Inc. Common Stock (MGRM) Stock
Based on ratings from 1 analysts Monogram Orthopaedics Inc. Common Stock's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on MGRM's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for MGRM is USD 4.00 over the next 12 months. The maximum analyst target price is USD 4 while the minimum anlayst target price is USD 4.
Unfortunately we do not have enough data on MGRM's stock to indicate if its overvalued.
The last closing price of MGRM's stock was USD 2.58.
The most recent market capitalization for MGRM is USD 0.09B.
Based on targets from 1 analysts, the average taret price for MGRM is projected at USD 4.00 over the next 12 months.
This means that MGRM's stock price may go up by +55.04% over the next 12 months.
We can't find any ETFs which contains Monogram Orthopaedics Inc. Common Stock's stock.
As per our most recent records Monogram Orthopaedics Inc. Common Stock has 28 Employees.
Monogram Orthopaedics Inc. Common Stock's registered address is 3913 Todd Lane, Austin, TX, United States, 78744.
You can get more information about it from Monogram Orthopaedics Inc. Common Stock's website at https://www.monogramorthopedics.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for MGRM !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
